Aveanna Healthcare Holdings Inc. (AVAH) — closed signal from September 18, 2025
Partial Published before the outcome was known, scored automatically when the window closed on December 17, 2025.
Predicted vs. what happened
What happened
Reached 77% of the predicted growth at its peak, without hitting the target.
The thesis — published September 18, 2025
Aveanna pushed its debt deadlines out to 2032, easing financial pressure and helping the stock reach new highs with very upbeat investor mood. Near-term moves are choppy, so we plan to buy on dips and add only if buying strength clearly improves and the price stays above its recent average. With better liquidity and a market more open to risk, a 1-3 month re-pricing looks possible with careful position size.
Primary drivers
- Debt maturities moved to 2032, easing near-term cash strain and lowering risk
- Stock is trading close to its highest level over the past 12 months
- Investor mood is very positive, supporting steady interest from buyers
- Wait for dips first, then add when buying strength clearly returns
How it played out
AVAH: target missed after a partial rise
Lyra published AVAH at 8.39 on 2025-09-18 with a short-term thesis for 30% growth. The thesis pointed to debt maturities moved to 2032, less near-term cash strain, a stock trading close to its highest level over the past 12 months, and very positive investor mood. It also called for waiting for dips and adding only if buying strength returned.
Inside the window, AVAH rose to 10.32 on 2025-10-21, a 23% peak gain. The 10.91 target was never reached. By 2025-12-17, it ended at 8.94. The thesis partly played out, but the target missed.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.